Navigation Links
Misonix Reports First Quarter Fiscal Year 2009 Financial Results
Date:11/13/2008

Revenues Increased 7.4%; Net Income of $.05 per Diluted Share

FARMINGDALE, N.Y., Nov. 13 /PRNewswire-FirstCall/ -- Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, today reported financial results for its fiscal year 2009 first quarter ended September 30, 2008. Michael A. McManus, Jr., President and Chief Executive Officer, and Richard Zaremba, Senior VP and Chief Financial Officer, will host a conference call at 4:30 p.m. Eastern on Thursday, November 13, 2008 to discuss the Company's first quarter financial results.

-- Revenues increased 7.4% to $11.3 million

-- Reported net income of $320,000 or $.05 per diluted share

-- The Company reported the following operational achievements:

-- Entered a new, three year exclusive distribution agreement in Russia

for the Sonablate 500(R)

-- Received second FDA approval for the Sonablate 600(R) Soft Tissue

Ablation System

-- Entered a new two year exclusive distribution agreement in Czech

Republic for Sonastar(TM), SonicOne(R) and BoneScalpel(TM)

Revenues for the three months ended September 30, 2008 were $11.3 million, a 7.4% increase, when compared with revenues of $10.5 million for the same period in fiscal 2008. The increase is due to a $621,000 increase in sales of laboratory and scientific products to $5.9 million and a $154,000 increase in medical device products sales to $5.4 million. The increase in sales of medical device products is due to a $173,000 increase in therapeutic medical device products partially offset by a $1
'/>"/>

SOURCE Misonix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Misonix Schedules First Quarter Fiscal Year 2009 Financial Results Conference Call; November 13, 2008 at 4:30 P.M. Eastern
2. Misonix Subsidiary, Sonora Medical Systems, Announces a Major Ultrasound Probe Study
3. Misonix To Present at The Rodman & Renshaw 10th Annual Healthcare Conference
4. Corgenix Reports Financial Results for First Quarter of Fiscal 2009
5. MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results
6. Spheris Reports Third Quarter 2008 Results
7. MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results
8. Symmetry Medical Reports Third Quarter 2008 Financial Results
9. EntreMed Reports Clinical Program Progress and Company Update
10. NBTY Reports Fourth Quarter and Fiscal Year Results
11. IPC The Hospitalist Company Reports Record Third Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 03, 2015 The North ... to grow from $1,224.6 million to $1,694.6 ... 2014 and 2019. , Browse through the ... market for an analysis of industry trends ... tables and figures., http://www.micromarketmonitor.com/market/north-america-application-delivery-network-adn-7381582251.html , ...
(Date:3/3/2015)... March 03, 2015 Dallas plastic ... chairman of the upcoming Dallas Rhinoplasty Symposium, to be ... day symposium, which is attended by plastic surgeons and ... surgeons with detailed information on current topics, emerging techniques, ... rhinoplasty surgery . , The symposium will cover ...
(Date:3/3/2015)... San Jose, CA (PRWEB) March 03, 2015 ... cross-device computing and collaboration, announces Mirroring360 is now available ... Available for download from the Moverio Apps Market ... redirect their mobile device experience to the Epson Moverio ... empowering new usage models. , The Epson ...
(Date:3/3/2015)... 03, 2015 Birth Boot Camp ... they now have over 130 certified instructors in more ... Germany. In addition, the company recently launched a new ... childbirth educator certification program . Birth Boot Camp is ... birth partner. The practical information can be used by ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 OncLive® ... Center have joined forces to share news about ... today. The collaboration is part of OncLive’s Strategic ... alliance, OncLive’s editorial and marketing teams will partner ... Cancer Institute-designated cancer center, to highlight accomplishments. They ...
Breaking Medicine News(10 mins):Health News:The North American Application Delivery Network Market is Estimated to Reach $1,694.6 Million in 2019- A Report By MicroMarket Monitor 2Health News:The North American Application Delivery Network Market is Estimated to Reach $1,694.6 Million in 2019- A Report By MicroMarket Monitor 3Health News:Dr. Rod Rohrich to Chair 32nd Annual Dallas Rhinoplasty Symposium 2Health News:Dr. Rod Rohrich to Chair 32nd Annual Dallas Rhinoplasty Symposium 3Health News:Splashtop’s Mirroring360 Now Available for Epson® MoverioTM BT-200 Smart Glasses, Enabling Viewing of iOS Apps and Content on Glasses 2Health News:Splashtop’s Mirroring360 Now Available for Epson® MoverioTM BT-200 Smart Glasses, Enabling Viewing of iOS Apps and Content on Glasses 3Health News:Expectant Couples Worldwide Can Now Receive Training and Education in Natural Childbirth and Breastfeeding from Birth Boot Camp 2Health News:IU Simon Cancer Center Teams with OncLive® in Strategic Alliance Partnership 2Health News:IU Simon Cancer Center Teams with OncLive® in Strategic Alliance Partnership 3
... especially migraines, are more likely to be depressed,// feel ... symptoms, according to a study. ,The study involved ... the women surveyed, 593 reported episodic headache (fewer than ... (more than 15 headaches per month). Ninety percent of ...
... maximal therapy with minimal side effects - Scientists of ... School,// Greece, has been awarded a grant from the ... validation of new therapeutic strategies for cancer. ... activate a protein at the surface of ovarian, lung ...
... People suffering from muscular dystrophy should avoid over exercising, ... the arms or legs after exercise can be caused ... Germany Professional Association of Neurologists. ,Muscular dystrophy is ... over 30 forms of the condition have been identified. ...
... It sounds like something out of a very scary science ... tackled.// , A leading vet of Britain is ... the seasonal flu. ,Fred Landeg, deputy chief veterinary officer ... vets and farm workers before this year’s flu season. This ...
... cleft lip/palate faces predisposing factors to acquiring dental ... and provides strategies for early prevention. The study ... ,Cleft lip/palate is the most common congenital ... Patients with cleft conditions generally display poorer oral ...
... times are over for those who prefer relaxing with a ... study conducted by researchers from Charite Hospital Universitatsmedizin in Berlin, ... out with a study that shows adding milk to your ... ,Tea is known to contain flavonoids like catechins, ...
Cached Medicine News:Health News:Avian Nightmare 2
(Date:3/3/2015)... , March 3, 2015 Depomed, Inc. (NASDAQ: ... at the 27 th Annual Roth Conference in ... for 12:30 pm ET (9:30 am PT) Tuesday, March 10, 2015. ... webcast can be accessed via the Investor Relations page of ... the webcast will be archived for 30 days on the ...
(Date:3/3/2015)... Denovo Biopharma, LLC, today announced that ... agonist), a late-stage neuroscience drug, from Eli Lilly ... rights to develop, manufacture and commercialize pomaglumetad globally, ... rights, data, and information. Lilly has an option ... for predetermined undisclosed financial terms.  ...
(Date:3/3/2015)... March 3, 2015  Blueprint Medicines today announced ... and commercialize novel drug candidates for an undisclosed ... a rare genetic disease. Blueprint Medicines will apply ... optimize drug candidates and will conduct all research ... New Drug (IND) application with the Food and ...
Breaking Medicine Technology:Depomed To Present At 27th Annual Roth Conference 2Denovo Biopharma Licenses Late-Stage Neuroscience Drug From Lilly For Development As A Personalized Medicine 2Blueprint Medicines Announces Strategic Collaboration with Alexion to Advance Kinase Drug Candidates in Rare Genetic Disease 2
... Medical Partners, the specialty pharmaceutical subsidiary of H. ... cold chain services agreement with Cardium Therapeutics (NYSE ... and regenerative medicine company, to support its recently ... professional-use, syringe-based wound care product used in the ...
... Care Corporation ("CompCare") (OTC BB: CHCR), a leading behavioral ... for managed care companies throughout the U.S., is pleased ... doubled to $71,210,000 compared to revenues of $35,214,000 in ... Chief Executive Officer said, "To continue our upward growth ...
Cached Medicine Technology:Smith Medical Partners Announces Logistics Agreement for Cardium's National Distribution of Excellagen™ 2Smith Medical Partners Announces Logistics Agreement for Cardium's National Distribution of Excellagen™ 3Comprehensive Care Corporation Doubles Its 2011 Revenues to Over $71 Million 2Comprehensive Care Corporation Doubles Its 2011 Revenues to Over $71 Million 3
... (1.5x) Gonio lens will enable visualization of ... mirror lens is the industry preferred standard ... features : , Crispest, clearest imaging ... unattainable with Gonio lenses., 4 equally angled ...
... alternative to bulky biometry devices that have ... AP2000 is the world's only battery-operated, fully ... the market today. Each unit weighs a ... perform multiple functions, namely: auto data capture, ...
... The PiGalileo™ ... System from PLUS ... Surgery technology and ... technologies to assist ...
... a low TLR (<1%) and stroke rate ... and long-term durability., , , High Radial ... carotid artery, increasing lumen diameter with chronic ... Minimal stent shortening, low profile design, Cordis ...
Medicine Products: